Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience

被引：0
|
作者：
Colussi, Lara [1 ]
Dagri, Arianna [2 ]
Pastore, Serena [3 ]
Tommasini, Alberto [1 ,3 ]
Pin, Alessia [3 ]
Taddio, Andrea [1 ,3 ]
机构：
[1] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy
[2] Univ Udine, Dept Med DAME, Div Pediat, Udine, Italy
[3] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2024年 / 27卷 / 08期
关键词：
LOCALIZED SCLERODERMA;
D O I：
10.1111/1756-185X.15295
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Immunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats - Comparison of juvenile and adult responses
    Collinge, Mark
    Ball, Douglas J.
    Bowman, Christopher J.
    Nilson, Andrea L.
    Radi, Zaher A.
    Vogel, W. Mark
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2018, 94 : 306 - 322
  • [42] Lung Transplantation In Scleroderma-Related Lung Disease: A Single-Center Experience
    Goodarzi, A.
    Sinha, N.
    Kaleekal, T.
    Youssef, J. G.
    Bruckner, B.
    Scheinin, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [43] Successful treatment of prurigo nodularis with tofacitinib: The experience from a single center
    Liu, Taoming
    Chu, Yuqi
    Wang, Yuqian
    Zhong, Xinyue
    Yang, Changyi
    Bai, Juan
    Fang, Hong
    Qiao, Jianjun
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (05) : E293 - E295
  • [44] Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience
    Barut, Kenan
    Adrovic, Amra
    Sahin, Sezgin
    Tarcin, Gurkan
    Tahaoglu, Gulberk
    Koker, Oya
    Yildiz, Mehmet
    Kasapcopur, Ozgur
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (09) : 1661 - 1669
  • [45] ORAL TOFACITINIB FOR TREATMENT OF CHRONIC POUCHITIS - A PROSPECTIVE, SINGLE-CENTER PILOT STUDY
    Syal, Gaurav
    Mishkin, Daniel
    Banty, Andrea
    Lee, Susie
    Fontelera-Sebial, Norma
    Hampton, Melissa
    Ziring, David
    Melmed, Gil
    GASTROENTEROLOGY, 2023, 164 (06) : S1138 - S1139
  • [46] JAAD Game Changers: Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (05) : 1028 - 1028
  • [47] Abatacept as Adjunct Therapy for the Calcinosis of Juvenile Dermatomyositis: A Single-Center Experience
    DeGuzman, Marietta
    Singla, Saimun
    Mizesko, Melissa
    Sagcal-Gironella, Anna Carmela
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 136 - 137
  • [48] Biotherapy in juvenile idiopathic arthritis Moroccan patients: a single-center experience
    Bouayed, Kenza
    Hamraoui, Dalal
    Mikou, Nabiha
    Sakhi, Asmaa
    Hilmi, Wassim
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [49] Platelet-rich plasma for the treatment of scleroderma-associated ulcers: a single-center experience and literature review
    Condorelli, Alessandra Grazia
    Paganelli, Alessia
    Marraccini, Chiara
    Ficarelli, Elena
    Motolese, Alfonso
    Contu, Luca
    Motolese, Alberico
    DERMATOLOGY REPORTS, 2024, 16 (03)
  • [50] TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS - THE RESULTS OF RUSSIAN NATIONAL REGISTER OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
    Gaydukova, Inna
    Mazurov, V.
    Zhilyaev, Evgeniy
    Grabovetskaya, Iuliia
    Marusenko, Irina
    Vasilenko, Elizaveta
    Abdulganieva, Diana
    Smitienko, Ilia
    Misiyuk, Anna
    Lukina, Galina
    Knyazeva, Larisa
    Kalinina, Elena
    Samigullina, Ruzana
    Bondareva, Irina
    Yudina, Natalya
    Lapkina, N.
    Nasonov, Evgeny
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 359 - 360
12345